122 related articles for article (PubMed ID: 14973089)
1. Inverse association between prostate cancer and the use of calcium channel blockers.
Debes JD; Roberts RO; Jacobson DJ; Girman CJ; Lieber MM; Tindall DJ; Jacobsen SJ
Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):255-9. PubMed ID: 14973089
[TBL] [Abstract][Full Text] [Related]
2. A population-based study of daily nonsteroidal anti-inflammatory drug use and prostate cancer.
Roberts RO; Jacobson DJ; Girman CJ; Rhodes T; Lieber MM; Jacobsen SJ
Mayo Clin Proc; 2002 Mar; 77(3):219-25. PubMed ID: 11888024
[TBL] [Abstract][Full Text] [Related]
3. Calcium channel blocker use and the risk of prostate cancer.
Vezina RM; Lesko SM; Rosenberg L; Shapiro S
Am J Hypertens; 1998 Dec; 11(12):1420-5. PubMed ID: 9880123
[TBL] [Abstract][Full Text] [Related]
4. Antiarrhythmic drug usage and prostate cancer: a population-based cohort study.
Kao LT; Huang CC; Lin HC; Huang CY
Asian J Androl; 2018; 20(1):37-42. PubMed ID: 28857052
[TBL] [Abstract][Full Text] [Related]
5. Calcium channel blockers and the incidence of breast and prostate cancer: A meta-analysis.
Thakur AA; Wang X; Garcia-Betancourt MM; Forse RA
J Clin Pharm Ther; 2018 Aug; 43(4):519-529. PubMed ID: 29656432
[TBL] [Abstract][Full Text] [Related]
6. Calcium Channel Blocker Use and the Risk for Prostate Cancer: A Population-Based Nested Case-Control Study.
Rotshild V; Azoulay L; Feldhamer I; Perlman A; Muszkat M; Matok I
Pharmacotherapy; 2019 Jun; 39(6):690-696. PubMed ID: 30917404
[TBL] [Abstract][Full Text] [Related]
7. Calcium-channel blockers and risk of cancer.
Jick H; Jick S; Derby LE; Vasilakis C; Myers MW; Meier CR
Lancet; 1997 Feb; 349(9051):525-8. PubMed ID: 9048789
[TBL] [Abstract][Full Text] [Related]
8. Cancer risk in users of calcium channel blockers.
Olsen JH; Sørensen HT; Friis S; McLaughlin JK; Steffensen FH; Nielsen GL; Andersen M; Fraumeni JF; Olsen J
Hypertension; 1997 May; 29(5):1091-4. PubMed ID: 9149671
[TBL] [Abstract][Full Text] [Related]
9. Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: the nurses' health study.
Michels KB; Rosner BA; Walker AM; Stampfer MJ; Manson JE; Colditz GA; Hennekens CH; Willett WC
Cancer; 1998 Nov; 83(9):2003-7. PubMed ID: 9806660
[TBL] [Abstract][Full Text] [Related]
10. Absence of a deleterious effect of calcium channel blockers in patients with left ventricular dysfunction after myocardial infarction: The SAVE Study Experience. SAVE Investigators. Survival and Ventricular Enlargement.
Hager WD; Davis BR; Riba A; Moye LA; Wun CC; Rouleau JL; Lamas GA; Pfeffer MA
Am Heart J; 1998 Mar; 135(3):406-13. PubMed ID: 9506325
[TBL] [Abstract][Full Text] [Related]
11. Do calcium channel blockers increase the risk of cancer?
Pahor M; Guralnik JM; Salive ME; Corti MC; Carbonin P; Havlik RJ
Am J Hypertens; 1996 Jul; 9(7):695-9. PubMed ID: 8806983
[TBL] [Abstract][Full Text] [Related]
12. Use of Calcium Channel Blockers and Risk of Breast Cancer: A Population-based Cohort Study.
Azoulay L; Soldera S; Yin H; Bouganim N
Epidemiology; 2016 Jul; 27(4):594-601. PubMed ID: 27031042
[TBL] [Abstract][Full Text] [Related]
13. No association between calcium channel blocker use and confirmed bleeding peptic ulcer disease.
Smalley WE; Ray WA; Daugherty JR; Griffin MR
Am J Epidemiol; 1998 Aug; 148(4):350-4. PubMed ID: 9717878
[TBL] [Abstract][Full Text] [Related]
14. Cancer risk and mortality in users of calcium channel blockers. A cohort study.
Sørensen HT; Olsen JH; Mellemkjaer L; Marie A; Steffensen FH; McLaughlin JK; Baron JA
Cancer; 2000 Jul; 89(1):165-70. PubMed ID: 10897013
[TBL] [Abstract][Full Text] [Related]
15. No evidence for increased prostate cancer risk among calcium channel blockers user.
Fan Y; Zhou Y; Gong D; Zou C
Int J Cardiol; 2015 Dec; 201():255-7. PubMed ID: 26301650
[No Abstract] [Full Text] [Related]
16. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
17. Calcium channel blockers and cancer.
Cohen HJ; Pieper CF; Hanlon JT; Wall WE; Burchett BM; Havlik RJ
Am J Med; 2000 Feb; 108(3):210-5. PubMed ID: 10723975
[TBL] [Abstract][Full Text] [Related]
18. Association between captopril, other antihypertensive drugs and risk of prostate cancer.
Ronquist G; Rodríguez LA; Ruigómez A; Johansson S; Wallander MA; Frithz G; Svärdsudd K
Prostate; 2004 Jan; 58(1):50-6. PubMed ID: 14673952
[TBL] [Abstract][Full Text] [Related]
19. Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status.
Jacobsen SJ; Jacobson DJ; Girman CJ; Roberts RO; Rhodes T; Guess HA; Lieber MM
J Urol; 1999 Oct; 162(4):1301-6. PubMed ID: 10492184
[TBL] [Abstract][Full Text] [Related]
20. Calcium-channel blockade and incidence of cancer in aged populations.
Pahor M; Guralnik JM; Ferrucci L; Corti MC; Salive ME; Cerhan JR; Wallace RB; Havlik RJ
Lancet; 1996 Aug; 348(9026):493-7. PubMed ID: 8757150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
